Integrative Foot & Ankle Centers of Washington Now Offers Erchonia’s LunulaLaser® for the Treatment of Onychomycosis!
FDA-approved, non-thermal, non-invasive, pain-free procedure with new clear nail growth in 6 months
Kirkland, WA – October 20, 2016 – Integrative Foot & Ankle Centers of Washington is now accepting appointments for Erchonia’s new LunulaLaser for the Treatment of Onychomycosis. The FDA-approved, non-invasive LunulaLaser targets the fungus and stimulate an average of 6.1 mm* new clear nail growth at 6 months.
Erchonia’s LunulaLaser is ideal treatment because it offers effective, pain-free, non-thermal treatment—without side effects or dangerous smoke plumes as other hot lasers used to treat onychomycosis. LunulaLaser consists of (4) weekly treatments 12 minute treatments and severe cases 2 more treatments are done at 3 month apart. Clinical trial results demonstrated 46% of new clear nail growth at 6 months.
Erchonia’s LunulaLaser received FDA-clearance based on a double-blind, randomized, multi-site and placebo-controlled clinical trial. The LunulaLaser clinical trial proved 89% of patients respond to treatment.
For more information or to book an LunulaLaser consultation, please visit www.seattlefootdoctor.com or call (425) 678-3877.
About Erchonia Erchonia is the global leader in low level laser healthcare applications. For nearly 2 decades, Erchonia has been conducting research and development with the world’s leading physicians to advance the science of low level lasers. Erchonia created the low level laser category after the company was granted the first low level laser FDA clearance for any indication in 2002. Prior to market introduction, all Erchonia lasers are proven safe and effective through independent clinical trials. Currently thousands of Erchonia’s lasers are used daily to reduce body fat, eliminate pain, accelerate healing, treat acne, treat the appearance of cellulite, treat onychomycosis and veterinary applications. For additional information, visit www.erchonia.com.